186 related articles for article (PubMed ID: 32729085)
21. The effects of RNA editing in cancer tissue at different stages in carcinogenesis.
Kurkowiak M; Arcimowicz Ł; Chruściel E; Urban-Wójciuk Z; Papak I; Keegan L; O'Connell M; Kowalski J; Hupp T; Marek-Trzonkowska N
RNA Biol; 2021 Nov; 18(11):1524-1539. PubMed ID: 33593231
[TBL] [Abstract][Full Text] [Related]
22. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.
Kawahara Y; Zinshteyn B; Chendrimada TP; Shiekhattar R; Nishikura K
EMBO Rep; 2007 Aug; 8(8):763-9. PubMed ID: 17599088
[TBL] [Abstract][Full Text] [Related]
23. Detection of A-to-I Hyper-edited RNA Sequences.
Cohen-Fultheim R; Levanon EY
Methods Mol Biol; 2021; 2181():213-227. PubMed ID: 32729083
[TBL] [Abstract][Full Text] [Related]
24. RNA editing of human microRNAs.
Blow MJ; Grocock RJ; van Dongen S; Enright AJ; Dicks E; Futreal PA; Wooster R; Stratton MR
Genome Biol; 2006; 7(4):R27. PubMed ID: 16594986
[TBL] [Abstract][Full Text] [Related]
25. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
Nakano M; Nakajima M
Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
[TBL] [Abstract][Full Text] [Related]
26. miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.
Laganà A; Paone A; Veneziano D; Cascione L; Gasparini P; Carasi S; Russo F; Nigita G; Macca V; Giugno R; Pulvirenti A; Shasha D; Ferro A; Croce CM
Bioinformatics; 2012 Dec; 28(23):3166-8. PubMed ID: 23044546
[TBL] [Abstract][Full Text] [Related]
27. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
Velazquez-Torres G; Shoshan E; Ivan C; Huang L; Fuentes-Mattei E; Paret H; Kim SJ; Rodriguez-Aguayo C; Xie V; Brooks D; Jones SJM; Robertson AG; Calin G; Lopez-Berenstein G; Sood A; Bar-Eli M
Nat Commun; 2018 Jan; 9(1):461. PubMed ID: 29386624
[TBL] [Abstract][Full Text] [Related]
28. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
[TBL] [Abstract][Full Text] [Related]
29. Identifying RNA editing sites in miRNAs by deep sequencing.
Alon S; Eisenberg E
Methods Mol Biol; 2013; 1038():159-70. PubMed ID: 23872974
[TBL] [Abstract][Full Text] [Related]
30. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
[TBL] [Abstract][Full Text] [Related]
31. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
[TBL] [Abstract][Full Text] [Related]
32. Hypothesis: RNA editing of microRNA target sites in humans?
Liang H; Landweber LF
RNA; 2007 Apr; 13(4):463-7. PubMed ID: 17255198
[TBL] [Abstract][Full Text] [Related]
33. Proteome Diversification by RNA Editing.
Eisenberg E
Methods Mol Biol; 2021; 2181():229-251. PubMed ID: 32729084
[TBL] [Abstract][Full Text] [Related]
34. ADAR editing wobbles the microRNA world.
Das AK; Carmichael GG
ACS Chem Biol; 2007 Apr; 2(4):217-20. PubMed ID: 17455896
[TBL] [Abstract][Full Text] [Related]
35. Deciphering miRNAs' Action through miRNA Editing.
Correia de Sousa M; Gjorgjieva M; Dolicka D; Sobolewski C; Foti M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835747
[TBL] [Abstract][Full Text] [Related]
36. The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting.
Li L; Song Y; Shi X; Liu J; Xiong S; Chen W; Fu Q; Huang Z; Gu N; Zhang R
Genome Res; 2018 Jan; 28(1):132-143. PubMed ID: 29233923
[TBL] [Abstract][Full Text] [Related]
37. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing.
Lei T; Yuen KS; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2013 Dec; 94(Pt 12):2739-2744. PubMed ID: 24045110
[TBL] [Abstract][Full Text] [Related]
38. Prediction and preliminary validation of oncogene regulation by miRNAs.
Koscianska E; Baev V; Skreka K; Oikonomaki K; Rusinov V; Tabler M; Kalantidis K
BMC Mol Biol; 2007 Sep; 8():79. PubMed ID: 17877811
[TBL] [Abstract][Full Text] [Related]
39. Regulation of miRNA processing and miRNA mediated gene repression in cancer.
Bajan S; Hutvagner G
Microrna; 2014; 3(1):10-7. PubMed ID: 25069508
[TBL] [Abstract][Full Text] [Related]
40. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
Cho CJ; Myung SJ; Chang S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
